2021

1. Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

   BMC Cancer, Vol. 21, Núm. 1

2. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

   Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415